Ramalingam Ajit's Form 4 filing
Bio-Rad Laboratories, Inc.BIO · filed Jun 7, 2023
- Accession no.
- 0001062993-23-013074
- Filed
- Jun 7, 2023
- Trade date
- Jun 6, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $73.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ramalingam AjitCIK 0001807891 | Officer (SVP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | Bio-Rad A Common Stock | SSaleDisposed | −17.35 | $368.49 | −$6,393.3 | 181 | Direct | |
| Jun 6, 2023 | Bio-Rad A Common Stock | SSaleDisposed | −181 | $368.28 | −$66,658.68 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.